Literature DB >> 19084561

Amyloid-beta(25-35) impairs memory and increases NO in the temporal cortex of rats.

I Daniel Limón1, Alfonso Díaz, Liliana Mendieta, Germán Chamorro, Blanca Espinosa, Edgar Zenteno, Jorge Guevara.   

Abstract

beta-Amyloid plays an important role in the neurodegeneration process of Alzheimer's disease (AD), but its neurotoxic mechanisms are not clear. It has been associated with the increase of oxidative stress and cognitive impairment because the beta-amyloid peptide 25-35 (Abeta((25-35))) has the critical neurotoxic properties of the full-length Abeta(1-42). Our present study shows the role of Abeta((25-35)) when injected into the temporal cortex on the nitric oxide pathways, 3-nitrotyrosine, neuronal death, and the spatial memory of rats 1 month after the injection. Our data showed that Abeta((25-35)) increases oxidative stress, causes neuronal damage, and decreases spatial memory in rats. Notably, the injection of the fraction Abeta((25-35)) caused an increase of nNOS and iNOS immunoreactivity in the temporal cortex and hippocampus. We demonstrated a significant increase of reactive astrocytosis, which was accompanied by neuronal damage in the temporal cortex and hippocampus of rats injected with Abeta((25-35)). These data suggest that the fraction Abeta((25-35)) injected into the temporal cortex might contribute to understanding the role of nitric oxide on the biological changes related to the neuropathological progression and the memory impairment in AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084561     DOI: 10.1016/j.neures.2008.11.006

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  13 in total

1.  Differential proteomics analysis of specific carbonylated proteins in the temporal cortex of aged rats: the deterioration of antioxidant system.

Authors:  Qingsong Wang; Xuyang Zhao; Sizhi He; Yashu Liu; Mingrui An; Jianguo Ji
Journal:  Neurochem Res       Date:  2009-06-28       Impact factor: 3.996

2.  Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties.

Authors:  Orly Weinreb; Tamar Amit; Silvia Mandel; Moussa B H Youdim
Journal:  Genes Nutr       Date:  2009-09-10       Impact factor: 5.523

3.  Neurotropin® alleviates hippocampal neuron damage through a HIF-1α/MAPK pathway.

Authors:  Wen-Li Fang; De-Qiang Zhao; Fei Wang; Mei Li; Sheng-Nuo Fan; Wang Liao; Yu-Qiu Zheng; Shao-Wei Liao; Song-Hua Xiao; Ping Luan; Jun Liu
Journal:  CNS Neurosci Ther       Date:  2017-03-07       Impact factor: 5.243

4.  Role of β-hairpin formation in aggregation: the self-assembly of the amyloid-β(25-35) peptide.

Authors:  Luca Larini; Joan-Emma Shea
Journal:  Biophys J       Date:  2012-08-08       Impact factor: 4.033

Review 5.  Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD.

Authors:  Grace Y Sun; Yan He; Dennis Y Chuang; James C Lee; Zezong Gu; Agnes Simonyi; Albert Y Sun
Journal:  Mol Neurobiol       Date:  2012-04-03       Impact factor: 5.590

6.  Meloxicam-loaded nanocapsules as an alternative to improve memory decline in an Alzheimer's disease model in mice: involvement of Na(+), K(+)-ATPase.

Authors:  Francine R Ianiski; Catiane B Alves; Carla F Ferreira; Virginia C Rech; Lucielli Savegnago; Ethel A Wilhelm; Cristiane Luchese
Journal:  Metab Brain Dis       Date:  2016-02-27       Impact factor: 3.584

7.  Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints.

Authors:  Agnese Picco; M Cristina Polidori; Michela Ferrara; Roberta Cecchetti; Dario Arnaldi; Mauro Baglioni; Silvia Morbelli; Patrizia Bastiani; Irene Bossert; Giuliana Fiorucci; Andrea Brugnolo; Massimo Eugenio Dottorini; Flavio Nobili; Patrizia Mecocci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-12-03       Impact factor: 9.236

8.  Nitric oxide inactivation mechanisms in the brain: role in bioenergetics and neurodegeneration.

Authors:  Ricardo M Santos; Cátia F Lourenço; Ana Ledo; Rui M Barbosa; João Laranjinha
Journal:  Int J Cell Biol       Date:  2012-06-10

9.  Association of cerebrovascular dysfunction with the development of Alzheimer's disease-like pathology in OXYS rats.

Authors:  Natalia A Stefanova; Kseniya Yi Maksimova; Ekaterina A Rudnitskaya; Natalia A Muraleva; Nataliya G Kolosova
Journal:  BMC Genomics       Date:  2018-02-09       Impact factor: 3.969

10.  Ameliorating of Memory Impairment and Apoptosis in Amyloid β-Injected Rats Via Inhibition of Nitric Oxide Synthase: Possible Participation of Autophagy.

Authors:  Marjan Shariatpanahi; Fariba Khodagholi; Ghorbangol Ashabi; Azar Aghazadeh Khasraghi; Leila Azimi; Mohammad Abdollahi; Mohammad Hossein Ghahremani; Seyed Nasser Ostad; Farshid Noorbakhsh; Mohammad Sharifzadeh
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.